Shiah, Jane-Guo,Bhagat, Rahul,Blanda, Wendy M.,Nivaggioli, Thierry,Peng, Lin,Chou, David,Weber, David A.
申请号:
AU2020204362
公开号:
AU2020204362A1
申请日:
2020.06.30
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
#$%^&*AU2020204362A120200723.pdf#####METHODS OF TREATMENT OF OCULAR CONDITIONS WITH A SUSTAINED DRUG DELIVERY IMPLANT ABSTRACT Intraocular implants may include a corticosteroid and a biodegradable polymer associated with the corticosteroid to facilitate the release of the corticosteroid into an eye for a period of time. In some embodiments, ocular conditions, such as diabetic macular edema can be treated through administration of an intraocular implant including a corticosteroid and a biodegradable polymer associated with the corticosteroid to the eye of a human at a frequency of about once every six months to about once a year.WO 2015/073895 PCT/US2014/065804 7/7 cC) CV) 00 C cu z ~ co 14 0 0! 0! 0 LOf C) 0 ) C>; C w P.- z .E~ CCD E0' oE 0. CD 00